Dopamine clinical trials at UCSF
1 research study open to eligible people
Dopamine is a chemical messenger in the brain. UCSF is recruiting for a clinical trial about how it impacts social decision-making. The trial aims to develop models for understanding this influence.
open to eligible people ages 18-40
Developing theoretical, quantitative models of the basic cognitive mechanisms underlying human social decision-making, and understanding the influence of neuromodulators such as dopamine on these mechanisms, has important ramifications for both healthy and patient populations. In this proposal the investigators combine quantitative social measures, computational models, neuroimaging, and a pharmacological intervention to define the mechanisms of social decision-making.